Corporate Profile & Company History

Company name	Olympus Terumo Biomaterials Corp.
Representative	Manabu Ishikawa, President
Head Office	Daiwa Sasazuka Tower, 1-50-1 Sasazuka, Shibuya-ku, Tokyo 151-0073, Japan Map
Business activities	Research and development relating to biomaterials and regenerative medicine, including ceramic bone substitute and manufacture and sales of these products
Capitalization	72,070,000 yen
Major shareholder	Olympus Corporation
Business commencement	Octoberber 1, 2004
Employees	119 (as of August 1,2023)
Officers	President Manabu Ishikawa Vice President Takao Tabata Director Ayumi Yorita Director Osamu Koyata Director Shinji Motomura Auditor Daizo Motoyoshi Auditor Motohiko Kobuchi
Financing bank	Sumitomo Mitsui Banking Corporation

Company History

September 2004

Established Olympus Biomaterial Corp.

September 2005

Acquired HAp technologies from Sumitomo Osaka Cement Co., Ltd.

December 2006

Concluded the joint venture agreement with Terumo Corporation.

January 2007

Opened the manufacturing facility in Mishima, Shizuoka

April 2007

Changed the name to Olympus Terumo Biomaterials Corp.

December 2007

Acquired ISO 13485 certification

July 2009

Opened Logistics Center in Shinagawa, Tokyo

February 2015

Concluded an exclusive distribution agreement with Alcare Corporation for artificial dermis (medical applications)

May 2015

Opened the second Logistics Center in Fukuoka, Kyushu

June 2015

Launched our own HTO Plate System successfully, expanding the portfolio of the orthopedic metal implants

February 2016

Moved the Head Office to Sasazuka, Tokyo

March 2017

Get MDSAP certificate

August 2020

Mishima Factory Research and Development Center Acquired ISO14001

September 2021

Established an online shop for dental products

July 2023

GC Co., Ltd. takes over the development, manufacturing, and sales of collagen products and the sales of dental products.

August 2023

Becoming a wholly owned subsidiary of Olympus